Innate Pharma(IPHA)
$1.59+0.05 (+3.31%)
IPHA
Innate Pharma financials statements
$1.59
At close:+0.05 (+3.31%)
Want to see IPHA full AI Analyst Report?
Innate Pharma (IPHA) Income Statement
155 Followers
Innate Pharma Income Statement
Last quarter (Q2 2026), Innate Pharma's total revenue was €5.66M, a decrease of 54.13% from the same quarter last year. In Q2, Innate Pharma's net income was €-19.62M. See Innate Pharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 2.79M | € 12.62M | € 51.90M | € 57.67M | € 12.11M | |
| € 2.79M | € 12.62M | € 5.62M | € 6.01M | € -22.30M | |
| € 56.21M | € 64.20M | € 18.29M | € 63.44M | € 25.52M | |
| Depreciation and Amortization | € 5.09M | € 1.99M | € 5.09M | € 45.41M | € 4.60M |
| € -43.65M | € -46.91M | € -1.84M | € -12.28M | € -43.23M | |
| € -53.42M | € -51.58M | € -12.67M | € -57.42M | € -47.83M | |
| € 4.25M | € 2.10M | € 5.10M | € -547.00K | € 2.35M | |
| € -49.18M | € -49.47M | € -7.57M | € -57.97M | € -45.48M | |
| € -49.18M | € -49.47M | € -7.57M | € -58.10M | € -52.81M | |
| Per Share Metrics | |||||
| Basic EPS | € -0.53 | € -0.61 | € -0.09 | € -0.73 | € -0.57 |
| Diluted EPS | € -0.53 | € -0.61 | € -0.09 | € -0.73 | € -0.57 |
| Weighted Average Shares Outstanding | 89.42M | 81.05M | 84.11M | 79.59M | 79.54M |
| Weighted Average Shares Outstanding (Diluted) | 89.42M | 81.05M | 84.11M | 79.64M | 79.54M |
Currency in EUR
